UnitedHealth Group Incorporated $UNH Shares Newly Acquired by Epiq Partners LLC

Epiq Partners LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,227 shares of the healthcare conglomerate’s stock, valued at approximately $1,552,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. LFG Wealth Partners LLC increased its position in shares of UnitedHealth Group by 3.3% during the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock worth $355,000 after purchasing an additional 27 shares in the last quarter. Synergy Financial Group LTD increased its position in UnitedHealth Group by 3.1% during the second quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after buying an additional 27 shares during the period. Ares Financial Consulting LLC grew its position in shares of UnitedHealth Group by 7.2% during the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after acquiring an additional 28 shares during the last quarter. Hudock Inc. raised its position in UnitedHealth Group by 1.0% in the 2nd quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock valued at $1,182,000 after purchasing an additional 28 shares during the last quarter. Finally, Rockland Trust Co. increased its stake in UnitedHealth Group by 1.1% in the second quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock valued at $1,076,000 after purchasing an additional 29 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Mizuho increased their target price on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a research note on Monday, July 20th. Barclays increased their price objective on UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a research report on Monday, July 20th. Jefferies Financial Group upped their price target on UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a research note on Friday, July 17th. KeyCorp boosted their price objective on shares of UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Finally, Morgan Stanley lifted their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $465.75.

UnitedHealth Group Price Performance

NYSE:UNH traded down $1.09 during trading hours on Wednesday, hitting $375.23. The company’s stock had a trading volume of 5,623,183 shares, compared to its average volume of 7,358,639. The company has a market capitalization of $336.80 billion, a PE ratio of 24.15, a PEG ratio of 1.42 and a beta of 0.60. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The business’s 50-day moving average is $390.52 and its two-hundred day moving average is $379.64. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter last year, the firm posted $4.08 EPS. The business’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 19.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UNH was highlighted among CNBC “Final Trades,” providing a modest endorsement from market commentators. The broader segment also featured healthcare and defensive-income ideas, which may support investor interest in the stock. EQT, UnitedHealth, Clearway Energy And More On CNBC’s Final Trades
• Positive Sentiment: A Zacks analysis continues to classify UnitedHealth as a strong value stock, suggesting that its earnings power and depressed valuation may appeal to value-focused investors after the shares’ previous decline. Here’s Why UnitedHealth Group is a Strong Value Stock
• Positive Sentiment: UnitedHealth’s latest reported quarter exceeded consensus expectations for both earnings and revenue, while full-year 2026 guidance remains in the range of $19.50 to $20.00 per share. This provides a fundamental base for the recovery narrative.
• Neutral Sentiment: Investors are awaiting the company’s expected third-quarter earnings release. Key questions include whether medical-cost trends are stabilizing, whether Medicare Advantage margins can improve, and whether profitability gains will require additional member reductions. UnitedHealth Q3 Coming Up: Two Questions Investors Can’t Ignore
• Negative Sentiment: A Seeking Alpha analysis argues that the rebound from roughly $300 to the $440–$450 area has already priced in much of the margin, Medicare Advantage and Optum Health recovery. It rates UNH a sell because further upside may require flawless execution amid medical-cost inflation and weakness in commercial and Medicaid businesses. UnitedHealth: The Upside Is Gone
• Negative Sentiment: Reports about Medicare plan closures affecting hundreds of thousands of members highlight potential disruption and reputational risk for UnitedHealth, although some investors view the changes as part of a broader turnaround. The ultimate impact depends on member retention and regulatory execution. Medicare Plans Are Shutting Down

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.